Clinical Research Directory
Browse clinical research sites, groups, and studies.
Stockholm hyperTRIglyceridemia REGister (STRIREG) Study
Sponsor: Region Stockholm
Summary
The STRIREG study is a retrospective longitudinal general population-based register study including all individuals who had had at least one plasma Tg measurement between 1st January 2000 and 31st December 2021 at Karolinska University Laboratory or Unilabs AB in Region Stockholm (population 2.41 million 2021). The exclusion criteria were a lack of a unique Swedish personal identification number (PIN). The index population consisted of 1,460,184 individuals between the age 0 and 107 years. The index population was extended to form the complete cohort (n=3,607,819) by associating the parents and the siblings (n=2,147,635) to the indexes by interlinkage of personal identification numbers via the Multi-Generation register (see below). The study baseline for the index population was defined as the date for participant's first Tg measurement.
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
3607819
Start Date
2000-01-01
Completion Date
2027-12-31
Last Updated
2023-10-27
Healthy Volunteers
No
Conditions
Interventions
Heredity for cardiovascular disease
First degree relatives with a diagnosis of Cardiovascular disease.
Heredity for pancreatitis
First degree relatives with a diagnosis of pancreatitis.
Heredity for type 2 diabetes
First degree relatives with a diagnosis of type 2 diabetes.
Heredity for hypertriglyceridemia
First degree relatives with hypertriglyceridemia